Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CITA Biomedical to Bring SEC Filings Up-to-Date.


BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Oct. 12, 1999--

CITA CITA Committee for the Implementation of Textile Agreements
CITA Canadian Institute for Theoretical Astrophysics
CITA Center for Information Technology Accommodation (US; now the GSA IT Accommodation Division) 
 Biomedical Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:DTOXE) announced today that it is in the process of completing its SEC 10Q filings for the three-month periods ending March 31, 1999, and June 30, 1999.

According to CITA's president, Joseph Dunn, the company expects to file the 10Q for both periods shortly. The company will then be current with all of its SEC filings and will fully comply with NASD NASD

See: National Association of Securities Dealers


NASD

See National Association of Securities Dealers (NASD).
 requirements for continued listing on the OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 Electronic Bulletin Board.

In accordance with NASD compliance policies, the company's ticker symbol has been temporarily changed from DTOX to DTOXE. Upon completion of the two 10Q filings, the symbol will once again be DTOX.

Visit the company's Web site at http://www.citabio.com and http://www.cita1.com for more information.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 12, 1999
Words:134
Previous Article:ClassMates.com's Nostalgia-Based Site Experiences Rapid Growth.
Next Article:American Quantum Cycles Receives Floorplan Financing From TransAmerica.



Related Articles
CITA Biomedical SEC Filings Now Up-to-Date.
Communications Capital Corporation Announces Investment Opinion On CITA Biomedical.
CITA Biomedical Retains Investor Relations Network as Its External Financial Public Relations Counsel.
CITA Biomedical to Acquire AMGI; Acquisition Will Expand Operations by 60 Percent.
CITA Biomedical Receives Standard & Poor's Approval For Listing in Its Comprehensive Market Access Program.
A new weapon in the war on drugs: corporation unveils a new treatment for substance abusers. (Newsmakers).
Four assume roles on AASA's governing board. (Executive Committee Newcomers).
Multimodal could work: expert.
Pay-for-performance program focuses on Web-based quality data.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles